Factor VIII Inhibitors in Patients with Hemophilia A

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

1995 • 640 citations

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1992 • 613 citations

Acquired inhibitors of blood coagulation.

1972 • 531 citations

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

1993 • 482 citations

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

1994 • 352 citations

A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII Concentrate

1993 • 189 citations

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group

1993 • 179 citations

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group

1993 • 172 citations

The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors

1988 • 171 citations

Factor VIII Inhibitors in Previously Treated Haemophilia A Patients with a Double Virus-inactivated Plasma Derived Factor VIII Concentrate

1997 • 168 citations

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII

1993 • 164 citations

A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A

1994 • 162 citations

Prevalence of Inhibitors in a Population of 3435 Hemophilia Patients in France

1992 • 135 citations

Inhibitors in hemophilia patients: Current status and management

1994 • 84 citations

Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentrates

1987 • 77 citations

Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography

1992 • 72 citations

Incidence of Factor VIII Inhibitor Development in Hemophilia A Patients Treated with Less Pure Plasma Derived Concentrates

1994 • 69 citations

Factor VIII inhibitors.

1997 • 63 citations

Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs

1982 • 53 citations

Incidence of inhibitors in haemophiliacs. A review of the literature

1993 • 51 citations

Clinical Course of Factor VIII Inhibitors Developed after Exposure to a Pasteurised Dutch Concentrate Compared to Classic Inhibitors in Hemophilia A

1994 • 50 citations

Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII

1995 • 47 citations

Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitate

1993 • 47 citations

Factor VIII Inhibitors

1987 • 40 citations

WHY DO SO MANY HAEMOPHILIA A PATIENTS DEVELOP AN INHIBITOR?

1995 • 38 citations

The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93

1995 • 32 citations

Complications of Treatment

1989 • 31 citations

Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C

1991 • 27 citations

Incidence and Course of Inhibitors among Patients with Classic Hemophilia

1973 • 26 citations

Hemophilia: An Updated Review

1995 • 18 citations

Rethink about growth-hormone therapy for critically ill patients

1999 • 17 citations

Factor VIII inhibitors--an algorithmic approach to treatment.

1994 • 14 citations

Inhibitors in hemophilia A: are some products safer?

1994 • 13 citations

Factor VIII inhibitors

1993 • 3 citations